20 April 2004
CCR5-D32 heterozygosity does not contribute to slowing disease progression in paedric AIDS
Challenging differential diagnosis, Diagnostic / therapeutic accidents, Rare disease
Susana Alvarez , Salvador Resino , Dolores Gurbindo , Angeles MuEóz-FernándezCase Rep Clin Pract Rev 2004; 5(null):51-53 :: ID: 12261
Abstract
Background: Entry of human immunodeficiency type 1 virus (HIV-1) into target cells requires both CD(4) and one chemokine receptor. Viruses predominantly use two major co-receptors, CCR5 and
CXCR4. A 32-base pair (bp) deletion mutation in the β-chemokine receptor CCR5 gene has been associated with resistance against human immunodeficiency virus type 1 (HIV-1) infection and disease.Report: We have analysed the potential protection of this mutation in the CCR5 gene (CCR5-?32) n the course of pediatric AIDS of a 12-years-old child who had the CCR5/-?32ccr5 heterozygous genotype.Conclusions: Our results indicate that it did not confer any benefit to the progression of disease in any virological and immunological markers studied.
Keywords: CCR5, progressors, HIV-1, children, AIDS
652
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.954163
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.954178
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.954110
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.953469
Most Viewed Current Articles
07 Dec 2021 : Case report
26,914,694
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
06 Dec 2021 : Case report
179,963
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
21 Jun 2024 : Case report
123,687
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
08 May 2026 : Case report
93,503
DOI :10.12659/AJCR.952158
Am J Case Rep 2026; 27:e952158






